Richard Schulick, MD, MBA, FACS
Disclosures: Royalty-Co-Inventor of Patent-Aduro Biotech-coinventor of a patent that uses genetically modified Listeria to treat cancer. It is licensed to Aduro Biotech. This is managed by Johns Hopkins University,Consulting to which seeks expert consults for patients who contact them. This is managed by the University of Colorado,Royalty-GlaxoSmithKline-Other_Role-coinvertor of patent that uses CD112 pathway to alter immune response. Managed by University of Colorado,On Board of NOILE Immune. Not compensated-Other_Role
No Bio Available.